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CAM at Minority or Health Disparities 
Research Centers (R21)
The purposes of this initiative are to: 1) stimulate
high-quality, preliminary studies of complementary
and alternative medicine (CAM) at institutions com-
mitted to minority health research or health dispari-
ties research, as evidenced by having received a grant
from National Institutes of health (NIH) or the
Agency for Healthcare Research and Quality (AHRQ)
for a research center on minority health or health dis-
parities relating to racial and ethnic minority popula-
tions; 2) increase the knowledge base regarding CAM
and health disparities; 3) attract investigators experi-
enced in minority health and health disparities
research to the ﬁeld of CAM; and 4) provide a stable
scientiﬁc environment where CAM practitioners can
participate actively in rigorous research.
The purpose of this solicitation is to stimulate
research that will enhance the understanding of the
mechanisms of CAM interventions and increase the
knowledge base regarding the potential role of CAM
practices, including traditional indigenous medicine
practices, either in reducing and eliminating health
disparities, or regarding minority health. This pro-
gram announcement will support exploratory/
developmental (R21) research projects on CAM
interventions at institutions that have received NIH
or AHRQ awards for research centers on minority
health or health disparities. The infrastructure and
resources of these centers may be used to support
basic, preclinical, clinical, translational, and health
services research projects addressing issues relating to
CAM and minority health or health disparities. For
the purpose of this program announcement, an eligi-
ble institution is defined as one that has received
funding from NIH or AHRQ for a single organiza-
tional entity incorporating multiple research projects
and associated project cores. The list of program
announcements from which eligible centers are
funded may be found at the website (http://nccam.
nih.gov/announcements/disparitiesPAR.htm).
The National Center for Complementary and
Alternative Medicine (NCCAM) deﬁnes CAM prac-
tices as those that are “unproven by science and not
presently considered an integral part of conventional
medicine” (http://nccam.nih.gov/about/plans/2005/
index.htm). NCCAM groups the wide range of
CAM modalities into four domains: 1) mind–body
medicine; 2) biologically based practices; 3) manipu-
lative and body-based practices; and 4) energy medi-
cine. In addition, NCCAM studies whole medical
systems, such as Ayurvedic medicine, traditional
Chinese medicine, traditional indigenous medicine,
and homeopathy. Mind–body interventions use a
variety of techniques designed to enhance the mind's
capacity to affect body functions and symptoms.
Mind–body techniques that are considered
CAM include prayer, mental healing, and therapies
that use creative outlets such as art, music, or dance,
and meditation for selected purposes. Other tech-
niques that were considered CAM in the past have
become mainstream, such as patient support groups
and cognitive-behavioral therapy.
Biologically based practices for prevention and
therapy use foods and their components, diets, and
dietary supplements such as vitamins, herbs, and
other natural products.
Manipulation and body-based methods in
CAM are based on manipulation and/or movement
of one or more parts of the body. Examples include
chiropractic or osteopathic manipulation, and mas-
sage therapy.
Energy therapies are of two types: 1) biofield
therapies (e.g., qi gong, Reiki, and therapeutic
touch), which are intended to affect energy fields
that surround and penetrate the human body, and
2) bioelectromagnetic-based therapies that involve
the unconventional use of electromagnetic fields
such as pulsed fields, magnetic fields, or alternating
current or direct current ﬁelds for selected purposes.
Although numerous surveys document use of
CAM by the general population, less information is
available on CAM use by racial and ethnic minority
populations. NCCAM previously published the ini-
tiative “Secondary Analysis of Data on CAM Use in
Minority Populations” to stimulate research on this
subject. Some practices now considered to be CAM
have long histories of use as traditional practices in
populations and cultures outside the mainstream.
America's increasing cultural diversity and increasing
minority populations necessitate a better under-
standing of their views on health, illness, and health-
care. Because of the integral role of traditional
indigenous/CAM practices in these cultures, a better
understanding of these factors can provide insight
into health behaviors and beliefs of the populations,
generating information that may inform the delivery
of conventional health care and lead to reduced
health disparities.
At the same time, statistics document signiﬁcant
disparities for minority populations in health out-
comes, such as quality of life, as well as mortality,
processes, quality, and appropriateness of care, and
the prevalence of certain conditions or diseases.
DHHS has targeted health disparities in six condi-
tions—HIV/AIDS, cancer, cardiovascular diseases,
diabetes, adult and childhood immunizations, and
infant mortality—for elimination by the year 2010,
in response to which NIH has funded several
research centers to address these and other health
disparities. The centers funded by NIH for research
on minority health and health disparities research, as
well as the AHRQ centers for research on health dis-
parities, all can contribute to the objectives of this
program announcement.
While many CAM therapies are in extensive use
by the public, few have been thoroughly tested for
safety and/or efficacy. For this reason, the potential
role of traditional or CAM practices in the elimina-
tion of health disparities remains to be defined. As
part of its contribution to this effort, NCCAM seeks
to fund research to determine the safety and efﬁcacy
of CAM interventions regarding minority health and
the possible roles for CAM in contributing to the
elimination of racial and ethnic health disparities.
Research illuminating mechanisms of action for rele-
vant CAM interventions as well as outcomes of
CAM use for health disparities conditions or diseases
also are of interest. NCCAM intends to build on
research investments addressing health disparities or
minority health by soliciting applications from those
centers funded by NIH or AHRQ for research on
minority health or health disparities. By stimulating
high- quality, exploratory/developmental studies of
CAM at institutions with infrastructure and research
activities focusing on minority health or health dis-
parities, NCCAM seeks to generate new knowledge
regarding CAM as it relates to racial and ethnic
health disparities.
Centers for research on minority health or
health disparities span a broad research spectrum
including basic, preclinical, clinical, translational,
and health services research relating to minority
health and health disparities. To increase the under-
standing of all aspects of traditional and CAM prac-
tices as they relate to health disparities, this program
announcement invites institutions with NIH- or
AHRQ-funded minority health centers or health
disparities centers to submit applications on research
topics relating to CAM and minority health or health
disparities. Because NCCAM previously announced
the initiative, Secondary Analysis of Data on CAM
Use in Minority Populations (PAR-03-102), applica-
tions proposing epidemiologic studies of CAM use or
secondary analyses of data on CAM use will not be
considered responsive to this initiative.
The objective of this Funding Opportunity
Announcement (FOA) is to encourage the sub-
mission of high quality exploratory/developmental
studies investigating the spectrum of CAM and tra-
ditional indigenous medicine interventions as they
apply to racial and ethnic minority populations or
health disparities. Applications may propose research
projects for basic, preclinical, clinical, translational,
or health services research studies of CAM or tradi-
tional indigenous medicine interventions as they
relate to minority health or health disparities. Those
applications seeking funding for clinical research
grants may propose projects in any CAM domain in
order to provide preliminary data that can be used as
a foundation for larger clinical studies and illuminate
a possible role for traditional indigenous or CAM
practices in reducing and ultimately eliminating
health disparities in cancer, diabetes, cardiovascular
diseases (including stroke), HIV/AIDS, or other
minority health or health disparity condition. This
FOA seeks to stimulate research that will increase
the understanding of CAM in relation to minority
health conditions or identiﬁed health disparities and
identify possible roles for traditional or CAM prac-
tices in reducing and ultimately eliminating health
disparities. Clinical studies proposing projects
involving procedure-based CAM or traditional
indigenous medicine practices are required to
include a knowledgeable practitioner as part of the
research team.
The following list of research topics provides
examples of the types of research projects being
sought by this initiative. This list is illustrative, is not
exhaustive, is not intended to be exclusive, and is not
in priority order. In addition, NCCAM has identi-
ﬁed research areas of special interest as well as areas
that are subject to a short “pause” in new research
funding. Please see the NCCAM website (http://
nccam.nih.gov/research/priorities/index.htm#5) for
further information: 1) Mechanistic studies on the
spectrum of CAM modalities that might be useful
for health disparity diseases or conditions: biologi-
cally-based treatments, herbs, bioactive food compo-
nents, nutritional supplements, natural products,
homeopathy, manual therapies (such as spinal
manipulation and mobilization as performed in chi-
ropractic or osteopathic practices), bioenergy modal-
ities such as qi gong, Reiki, distant healing,
acupuncture, and others; 2) Mechanisms of action of
complex botanicals focusing on the cellular, molecu-
lar, endocrine, and metabolic changes induced in
vitro, in animal models, and in human subjects
treated with these botanicals; 3) Interactions
between CAM and conventional therapeutic modali-
ties, including but not limited to those of complex
botanicals with pharmaceutical drugs; 4) Projects
that study the effects of CAM interventions (includ-
ing botanical substances or other natural products)
alone or in combination with conventional therapy
on the progression of disease or clinical outcomes;
5) Studies on potential roles for CAM interventions
(e.g., homeopathic remedies, various energy modali-
ties, meditation, mind–body practices, etc.) in
patients to slow the progression of disease, decrease
symptoms, ameliorate medication side effects, or
improve quality of life; 6) Projects to characterizeand investigate the safety and efficacy of interven-
tions from traditional medicine systems (e.g., tradi-
tional indigenous medicine, traditional Chinese
medicine, Ayurveda, etc.) used to treat health dispar-
ity conditions/diseases; 7) Feasibility studies to test
and optimize parameters such as accrual rates, accep-
tance of randomization, compliance, delivery of the
intervention, appropriate inclusion/exclusion crite-
ria, and optimization of the overall protocol design
for planned clinical trials; 8) Studies to develop and
validate testing of biological and behavioral outcome
measures in humans for use in CAM clinical
research. These could include development and/or
validation of both the measurement procedure itself
and delivery to subjects. Examples include optimiza-
tion of imaging methods and enzymatic assays, and
development and validation of behavioral assessment
tools to be used in clinical trials; 9) Studies to deter-
mine if effect sizes described in the literature or clini-
cally significant effect sizes can be achieved;
10) Small clinical studies to determine safety, toxic-
ity, pharmacokinetics, pharmacodynamics, and the
optimal dosage of an intervention as a prelude to a
larger efﬁcacy trial; 11) Qualitative research, such as
detailed case studies and patient and health care
provider interviews, ethnographic or ethnobotanical
studies, to describe diagnostic and treatment
approaches; to explore patient and health care
provider preferences, beliefs and attitudes; and to
investigate the relevance of those approaches to
future clinical studies; 12) Studies of the effects of
CAM interventions on patient adherence to conven-
tional therapy; 13) Clinical studies of natural prod-
ucts, including functional foods, extracts, and their
components, shown to have strong in vitro activity
relating to a health disparity condition; 14) Studies
of the impact of CAM interventions on objective
and subjective measures of symptoms, well-being, or
quality of life; 15) Studies to address issues regarding
the impact of insurance availability and costs of
CAM on CAM use and the impact of managed care
on CAM use; 16) Outcomes studies that include
measurement of nonclinical patient-oriented vari-
ables as well as clinical variables in assessing results,
such as measures of the patient's health-related qual-
ity of life, patient satisfaction, personal preferences,
and functional abilities: for example, measuring the
effect of CAM use on the results of treatment; iden-
tifying health disparity conditions for which CAM
use appears to influence outcomes either positively
or unfavorably; determining whether CAM use
affects patient satisfaction or makes a difference in
the functional result of care, and whether CAM
interventions can be linked causally to specific out-
comes; 17) Studies that seek to clarify biomarkers of
exposure to functional foods and their bioactive
components, and determinants of biological
response involved with minority health and health
disparities.
This funding opportunity will use the NCCAM
R21 (Exploratory/Developmental Project) award
mechanisms. 
As an applicant, you will be solely responsible
for planning, directing, and executing the proposed
project. Applicants are encouraged to direct inquiries
regarding the appropriate mechanism to scientific/
research staff listed in the Section VII.1. Scientific/
Research Contacts.
The R21 awards are exploratory/developmental
research grants for support of pilot and feasibility
research designed to provide investigators with an
opportunity to produce preliminary data in support
of a larger project that may be submitted in the
future as a research project (R01) grant application.
Two NCCAM R21 funding mechanisms (http://
nccam.nih.gov/research/instructions/r21/index.htm)
are available: 1) Basic and Preclinical Research on
Complementary and Alternative Medicine and
2) NCCAM Exploratory/Developmental Grant for
Clinical Studies. Applicants are advised to check the
website above for the most current NCCAM R21
announcements, and also to abide by the application
guidance, allowable project period length, and direct
cost limits.
This FOA uses just-in-time concepts. It also
uses the modular budget formats (see the “Modular
Applications and Awards” section of the NIH
Grants Policy Statement. Speciﬁcally, if you are sub-
mitting an application with direct costs in each year
of $250,000 or less (excluding consortium Facilities
and Administrative [F&A] costs), use the PHS398
Modular Budget component provided in the SF424
(R&R) Application Package and SF424 (R&R)
Application Guide (see specifically Section 5.4,
“Modular Budget Component,” of the Application
Guide).
Exploratory/developmental grant support is for
new projects only; competing renewal (formerly
“competing continuation”) applications will not be
accepted. Up to two resubmissions (formerly
“revisions/amendments") of a previously reviewed
exploratory/developmental grant application may be
submitted. See NOT-OD-03-041, May 7, 2003.
Applicants must download the SF424 (R&R)
application forms and SF424 (R&R) Application
Guide for this FOA through Grants.gov/Apply.
Note: Only the forms package directly attached
to a speciﬁc FOA can be used. You will not be able
to use any other SF424 (R&R) forms (e.g., sample
forms, forms from another FOA), although some of
the "Attachment" ﬁles may be useable for more than
one FOA.
For further assistance, contact GrantsInfo: 301-
435-0714, telecommunications for the hearing
impaired: TTY 301-451-0088) or by e-mail:
GrantsInfo@nih.gov.
The letter of intent receipt date for this PAR is
15 October 2007, with the application receipt date
14 November 2007. The complete version of this
PA is available at http://grants.nih.gov/grants/
guide/pa-ﬁles/PAR-06-372.html.
Contact: Morgan N. Jackson, Division of
Extramural Research and Training, National Center
for Complementary and Alternative Medicine, 6707
Democracy Boulevard, Suite 401, Bethesda, MD
20892-5475 USA (for courier service, use the
Zip Code 20817 USA) 301-402-1278, e-mail:
mj145m@nih.gov; Sharon Ross, Division of Cancer
Prevention, National Cancer Institute, 6130
Executive Bouelvard, Room 3157, MSC 7328,
Bethesda, MD 20892-7328 USA, 301-594-7547,
fax: 301-480-3925, e-mail: rosssha@mail.nih.gov;
Mireille Kanda, National Center on Minority
Health and Health Disparities, National Institutes of
Health, 6707 Democracy Boulevard, Suite 800,
MSC-5465, Bethesda, Maryland 20892-5465 USA,
301-402-1366, fax: 301-480-4049, e-mail:
kandam@mail.nih.gov. Reference PAR-06-372.
Research Project Grant (Parent R01) 
The Research Project Grant (R01) is an award to
support a discrete, speciﬁed, circumscribed project to
be performed by named Project Directors/Principal
Investigators (PDs/PIs) in areas representing the
investigators’ specific interests and competencies,
based on the mission of the NIH. The R01 is the
original and historically the oldest grant mechanism
used by the NIH to support health-related research
and development.
The NIH awards R01 grants to institutions/
organizations of all types. This mechanism allows
the PDs/PIs to deﬁne the scientiﬁc focus or objective
of the research based on particular areas of interest
and competence. Although the PDs/PIs write the
grant application and are responsible for conducting
and supervising the research, the actual applicant is
the research institution/organization.
Research grant applications are assigned to an
NIH Institution or Center (IC) based on receipt and
referral guidelines and many applications are
assigned to multiple ICs with related research
interests.
Each IC maintains a website with funding
opportunities and areas of interest. Contact with an
IC representative may help focus the research plan
based on an understanding of the mission of the IC.
For specific information about the mission of each
NIH IC, see http://www.nih.gov/icd, which pro-
vides a brief summary of the research interests in
each IC and access to individual IC home pages.
This Funding Opportunity Announcement
(FOA) will use the Research Project Grant (R01)
award mechanism. 
The applicant will be solely responsible for
planning, directing, and executing the proposed
project. 
This FOA uses just-in-time information con-
cepts. It also uses the modular as well as the non-
modular budget formats (see http://grants.nih.
gov/grants/funding/modular/modular.htm).
Specifically, if you are a U.S. organization and
are submitting an application with direct costs in
each year of $250,000 or less (excluding consortium
Facilities and Administrative [F&A] costs), use the
PHS398 Modular Budget component provided in
the SF424 (R&R) Application Package and SF424
(R&R) Application Guide (see specifically Section
5.4, “Modular Budget Component,” of the
Application Guide).
United States applicants requesting more than
$250,000 in annual direct costs and all foreign
applicants must complete and submit detailed bud-
get requests using the Research & Related Budget
component found in the application package for this
FOA. See NOT-OD-06-096, August 23, 2006. 
Applicants must download the SF424 (R&R)
application forms and the SF424 (R&R) Application
Guide for this FOA through Grants.gov/Apply.
Note: Only the forms package directly attached
to a speciﬁc FOA can be used. You will not be able
to use any other SF424 (R&R) forms (e.g., sample
forms, forms from another FOA), although some of
the "Attachment" ﬁles may be useable for more than
one FOA.
For further assistance, contact GrantsInfo: 301-
435-0714, (telecommunications for the hearing
impaired: TTY 301-451-0088) or by e-mail:
GrantsInfo@nih.gov.
The application submission dates are available
at http://grants.nih.gov/grants/funding/submission-
schedule.htm.
The complete version of this PA is available at
http://grants.nih.gov/grants/guide/pa-files/PA-07-
070.html.
Contacts: The complete list of agency contacts
is available at http://grants.nih.gov/grants/guide/
pa-ﬁles/PA-07-070.html. Reference: PA-07-070. 
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